Sign in

Private company

Bruker Cellular Analysis, Inc.

Bruker Cellular Analysis, Inc. is an American laboratory analytical instruments company, incorporated in Delaware.1 It is headquartered in Emeryville, California.1

Last updated Oct 21, 2026.

Overview

  • IndustryLaboratory Analytical Instruments1
  • HeadquartersEmeryville, California1
  • Incorporated inDE2
  • Business address5858 Horton Street, Suite 320, Emeryville, Ca 946082
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

68.4%Gross margin3
-124.8%Operating margin3
-124.7%Net margin3
-8.0%Revenue growth, 20223
-69.0%Return on equity3
-$55.6MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue14¢$24.8M
  • Research and development31¢$53.2M
  • Selling, general and admin55¢$95.1M
  • Interest1¢$910.0K
  • Income tax0¢$100.0K

Out of $78.6M in revenue.3 The company lost money this year.

Financial statements

Revenue453$78.6M in 2022+151% since 2018
0$25.0M$50.0M$75.0M$100.0M2018: $31.3M$31.3M20182019: $56.7M$56.7M2019+81%2020: $64.3M$64.3M2020+13%2021: $85.4M$85.4M2021+33%2022: $78.6M$78.6M2022−8%
Gross profit453$53.8M in 2022+133% since 2018
0$20.0M$40.0M$60.0M2018: $23.1M$23.1M20182019: $43.5M$43.5M2019+88%2020: $44.6M$44.6M2020+2%2021: $56.6M$56.6M2021+27%2022: $53.8M$53.8M2022−5%
Operating income453-$98.1M in 2022+363% since 2018
-$100.0M-$75.0M-$50.0M-$25.0M02018: -$21.2M-$21.2M20182019: -$16.5M-$16.5M2019−22%2020: -$40.4M-$40.4M2020+144%2021: -$70.8M-$70.8M2021+75%2022: -$98.1M-$98.1M2022+39%
Net income453-$98.0M in 2022+320% since 2018
-$100.0M-$75.0M-$50.0M-$25.0M02018: -$23.3M-$23.3M20182019: -$18.3M-$18.3M2019−22%2020: -$41.6M-$41.6M2020+127%2021: -$71.7M-$71.7M2021+72%2022: -$98.0M-$98.0M2022+37%
Fiscal year201720182019202020212022
Revenue$31.3M4$56.7M5$64.3M3$85.4M3$78.6M3
Cost of revenue$8.2M4$13.2M5$19.7M3$28.8M3$24.8M3
Gross profit$23.1M4$43.5M5$44.6M3$56.6M3$53.8M3
Research and development$29.1M4$38.4M5$47.2M3$58.6M3$53.2M3
Selling, general and admin$37.7M3$68.8M3$95.1M3
Operating expenses$127.3M3$151.8M3
Operating income-$21.2M4-$16.5M5-$40.4M3-$70.8M3-$98.1M3
Interest$2.2M4$1.4M5$1.4M3$1.2M3$910.0K3
Income before tax-$71.8M3-$97.9M3
Income tax$69.0K4$69.0K5$174.0K3-$55.0K3$100.0K3
Net income-$23.3M4-$18.3M5-$41.6M3-$71.7M3-$98.0M3
Earnings per share-$7.465-$1.393-$1.083-$1.423
Earnings per share (diluted)-$7.465-$1.393-$1.083-$1.423
Shares (weighted, basic)66.7M shares368.9M shares3
Shares (weighted, diluted)66.7M shares368.9M shares3

Compare Bruker Cellular Analysis, Inc. with another company

Corporate structure

Bruker Cellular Analysis, Inc. is part of a group headed by Bruker. 124 entities, 33 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Bruker Cellular Analysis, Inc.

  • Bruker Billerica, Massachusetts, United States
    • Bruker Cellular Analysis, Inc. Emeryville, California
    • Bruker (France) Subsidiary · Wissembourg, France
    • Anasys Instruments Corporation Subsidiary · California, United States
    • Biocrates Inc. Subsidiary · Delaware, United States
    • Biocrates Life Sciences AG Subsidiary · Austria
    • Biognosys, AG Subsidiary · Switzerland
    • BLI Europe International, LTD Subsidiary · United Kingdom
    • BLI International LLC Subsidiary · Delaware, United States
    • Bruker (Beijing) Scientific Technology Co., Ltd. Subsidiary · China
    • Bruker (Canada) Subsidiary · Canada
    • Bruker (Israel) Subsidiary · Israel
    • BRUKER (MALAYSIA) SDN. BHD. Subsidiary · Shah Alam, Malaysia
    • Bruker (United States) Subsidiary · United States
    • Bruker Arabia Limited Subsidiary · Saudi Arabia
    • Bruker Austria GmbH Subsidiary · Austria
    • Bruker AXS Holdings, Inc. Subsidiary · Delaware, United States
    • Bruker AXS LLC Subsidiary · Delaware, United States
    • Bruker Belgium S.A./N.V. Subsidiary · Belgium
    • Bruker BioSpin Corporation Subsidiary · Massachusetts, United States
    • Bruker BioSpin GmbH & Co. KG Subsidiary · Germany
    • Bruker BioSpin Holding SE Subsidiary · Germany
    • Bruker BioSpin Verwaltungs GmbH Subsidiary · Germany
    • Bruker Business Support Center sp. Z.o.o. Subsidiary · Poland
    • Bruker Daltonics GmbH & Co., KG Subsidiary · Germany
    • Bruker Daltonics Ltd. Subsidiary · United Kingdom
    • and 98 more

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Bruker Cellular Analysis, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$53.1M3 Dec 31, 2022$49.8M3 Dec 31, 2021+6.6%
Accumulated depreciation$29.2M3 Dec 31, 2022$21.8M3 Dec 31, 2021+34.1%
Property and equipment, net$23.8M3 Dec 31, 2022$28.0M3 Dec 31, 2021−14.8%
Operating-lease assets (leased space)$23.3M3 Dec 31, 2022$26.1M3 Dec 31, 2021−10.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$86.5M3 Dec 31, 2022$178.1M3 Dec 31, 2021−51.4%

Inventory

ItemLatestA year beforeChange
Inventory, total$18.9M3 Dec 31, 2022$14.5M3 Dec 31, 2021+29.7%
Raw materials$11.9M3 Dec 31, 2022$8.3M3 Dec 31, 2021+44.0%
Finished goods$6.9M3 Dec 31, 2022$6.3M3 Dec 31, 2021+10.6%

Leadership

Who has led Bruker Cellular Analysis, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Eric Hobbs2020–2022
  2. Siddhartha Kadia2022–2023

President

  1. Eric Hobbs2022

Chief financial officer

  1. Shaun Holt2020–2021
  2. Kurt Wood2021–2022
  3. Mehul Joshi2022–2023
2025
Board members and other officers (18)

Former names

  • PhenomeX Inc.Mar 21, 2023 to Oct 2, 20232
  • Berkeley Lights, Inc.Nov 15, 2016 to Mar 16, 20232

Timeline

  1. Oct 2, 20238-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights32
  2. Aug 17, 20238-K Other events33
  3. Aug 17, 20238-K Entered a material agreement; New debt or obligation34
  4. Aug 14, 20238-K Results of operations35
  5. Jul 7, 20238-K Ended a material agreement; Other events36
  6. Jun 23, 20238-K Listing notice or transfer37
  7. May 26, 20238-K Shareholder vote38
  8. May 11, 20238-K Results of operations39
  9. May 5, 20238-K Exit or restructuring costs40
  10. Apr 28, 20238-K Executive or director change41
  11. Apr 10, 20238-K Executive or director change42
  12. Mar 21, 20238-K Entered a material agreement; Completed an acquisition or sale; New debt or obligation43
  13. Mar 22, 2022New chief executive Siddhartha Kadia becomes CEO9
  14. Jul 16, 2020New chief executive Eric Hobbs becomes CEO10

Calendar

When it reported results

  1. Aug 14, 2023Reported quarterly or annual results35
  2. May 11, 2023Reported quarterly or annual results39
  3. Feb 23, 2023Reported quarterly or annual results44
  4. Jan 9, 2023Reported quarterly or annual results45
  5. Nov 8, 2022Reported quarterly or annual results46
  6. Aug 9, 2022Reported quarterly or annual results47
  7. May 9, 2022Reported quarterly or annual results48
  8. Feb 24, 2022Reported quarterly or annual results49

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

180 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 35 major events, 93 insider forms, 12 large holders, 32 other. The latest 20:

  1. Feb 8, 2024SC 13G/A EDGAR
  2. Oct 12, 202315-12G EDGAR
  3. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  4. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  5. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  6. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  7. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  8. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  9. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  10. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  11. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  12. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  13. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  14. Oct 3, 20234 FORM 4 SUBMISSION EDGAR
  15. Oct 3, 20233 FORM 3 SUBMISSION EDGAR
  16. Oct 2, 2023POSASR EDGAR
  17. Oct 2, 2023S-8 POS EDGAR
  18. Oct 2, 2023S-8 POS EDGAR
  19. Oct 2, 2023S-8 POS EDGAR
  20. Oct 2, 2023S-8 POS EDGAR

The 180 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

10 open-market trades by officers, directors and large owners since October 2021: 5 buys and 5 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Oct 20, 2022McClaskey James PaulSVP, Chief Accounting OfficerSale122$1.99$243Form 4
May 13, 2022Hobbs EricVP, Global OperationsSale6,198$4.97$30.8KForm 4
May 13, 2022Hobbs EricVP, Global OperationsSale7,531$4.97$37.4KForm 4
May 12, 2022Hobbs EricVP, Global OperationsSale123,062$4.31$530.4KForm 4
May 11, 2022Hobbs EricVP, Global OperationsSale98,011$4.18$409.7KForm 4
Mar 11, 2022Chiminski John RDirectorBuy18,000$5.18$93.2KForm 4
Mar 11, 2022LUCIER GREGORY TDirectorBuy50,000$5.24$262.0KForm 4
Mar 10, 2022Hopfield JessicaDirectorBuy80,000$6.28$502.4KForm 4
Nov 8, 2021Rothman JamesDirectorBuy4,000$24.35$97.4KForm 4
Nov 5, 2021LUCIER GREGORY TDirectorBuy20,704$24.15$500.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Bruker Cellular Analysis, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARBruker Cellular Analysis, Inc.1
  • CIK0001689657
  • Employer ID (EIN)35-24153901
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3826 Laboratory Analytical Instruments1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address5858 Horton Street, Suite 320, Emeryville, CA 946081
  • Phone510-858-28551
  • Shares outstanding99,296,604 as of Jul 31, 20238
  • Public float$300.0M as of Jun 30, 20223
  • On EDGAR sinceNov 15, 20161
  • Filings366 in all: 4 (173), 8-K (49), 3 (26), 425 (12), SC 13G (11), 10-Q (10), CORRESP (8), SC 13G/A (8)1
    All 43 form types

    S-8 (5), S-8 POS (5), 4/A (4), 424B3 (4), UPLOAD (4), 10-K (3), 144 (3), DEF 14A (3), EFFECT (3), SC14D9C (3), 424B4 (2), D (2), DRS (2), S-1 (2), S-1/A (2), SC 14D9/A (2), SC TO-T/A (2), 15-12G (1), 25-NSE (1), 5 (1), 8-A12B (1), ARS (1), CERT (1), D/A (1), DEFA14A (1), DRS/A (1), DRSLTR (1), POSASR (1), S-1MEF (1), S-3ASR (1), S-4 (1), S-4/A (1), SC 14D9 (1), SC TO-C (1), SC TO-T (1)

  • Latest filingsAnnual report (10-K) Feb 23, 2023
    Quarterly report (10-Q) Aug 14, 2023
    Proxy statement (DEF 14A) Apr 14, 2023
    Latest 8-K (8-K) Oct 2, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
    SEC EDGAROther events
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57